Standardization of autoantibody testing: a paradigm for serology in rheumatic diseases
- 26 November 2013
- journal article
- review article
- Published by Springer Nature in Nature Reviews Rheumatology
- Vol. 10 (1) , 35-43
Abstract
Autoantibody measurement is an excellent tool to confirm the diagnosis of rheumatic autoimmune diseases. Hence, reliability and harmonization of autoantibody testing are essential, but these issues are still a matter of debate. Intrinsic variability in analytes and reagents as well as heterogeneity of the techniques are the main reasons for discrepancies in inter-laboratory variations and reporting of test results. This lack of reliability might be responsible for wrong or missed diagnoses, as well as additional costs due to assay repetition, unnecessary use of confirmatory tests and/or consequent diagnostic investigations. To overcome such issues, the standardization of autoantibody testing requires efforts on all aspects of the assays, including the definition of the analyte, the pre-analytical stages, the calibration method and the reporting of results. As part of such efforts, the availability of suitable reference materials for calibration and quality control would enable the development of a reliable reference system. Strong-positive sera from patients have been used as reference materials in most of the autoantibody assays for rheumatic diseases; however, antigen-affinity-purified immunoglobulin fractions or in some cases reliable monoclonal antibody preparations offer more adequate tools for standardization. Systematic assessments of reference materials are currently underway, and preliminary results appear to be encouraging.Keywords
This publication has 71 references indexed in Scilit:
- The influence of ACPA status and characteristics on the course of RANature Reviews Rheumatology, 2012
- Discrimination and variable impact of ANCA binding to different surface epitopes on proteinase 3, the Wegener’s autoantigenJournal of Autoimmunity, 2010
- Autoantibodies as predictive tools in systemic sclerosisNature Reviews Rheumatology, 2010
- Standardization of protein biomarker measurements: Is it feasible?Scandinavian Journal of Clinical and Laboratory Investigation, 2010
- Predictive value of anti-dsDNA autoantibodies: Importance of the assayAutoimmunity Reviews, 2008
- Analytical and Diagnostic Characteristics of 11 2nd- and 3rd-Generation Immunoenzymatic Methods for the Detection of Antibodies to Citrullinated ProteinsClinical Chemistry, 2007
- Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studiesAnnals of the Rheumatic Diseases, 2007
- Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature reviewAnnals of the Rheumatic Diseases, 2006
- Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritisRheumatology, 2004
- Characterization of IgG monoclonal anti‐cardiolipin/anti‐β2GP1 antibodies from two patients with antiphospholipid syndrome reveals three species of antibodiesBritish Journal of Haematology, 1999